Intranasal Administration of a Meningococcal Outer Membrane Vesicle Vaccine Induces Persistent Local Mucosal Antibodies and Serum Antibodies with Strong Bactericidal Activity in Humans

Bjørn Haneberg, Rolf Dalseg, Elisabeth Wedege, +8

Infection and Immunity

The Norwegian immunisation register – SYSVAK

Lill Trogstad, G Ung, Maria Elisabeth Hagerup-Jenssen, +3

Eurosurveillance

VaccinationPrimary ImmunodeficiencyVaccine SafetyEpidemiologyAdverse Events +11

Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice

Rolf Dalseg, Elisabeth Wedege, Johan Holst, +3

Vaccine

Medical MicrobiologyOuter Membrane VesiclesMucosal VaccinationImmunologyGroup B Meningococci +4

A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers

Aud Katrine Herland Berstad, Jens J. Holst, L O Frøholm, +4

Journal of Medical Microbiology

Monitoring of timely and delayed vaccinations: a nation-wide registry-based study of Norwegian children aged < 2 years

Øystein Rolandsen Riise, Ida Laake, Marianne A. Riise Bergsaker, +3

BMC Pediatrics

A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin

Aud Katrine Herland Berstad, Johan Holst, B Møgster, +2

Vaccine

VaccinationMucosal VaccinationCross-protectionVaccine DevelopmentImmunology +4

Oral Spray Immunization May Be an Alternative to Intranasal Vaccine Delivery to Induce Systemic Antibodies but not Nasal Mucosal or Cellular Immunity

Hilde Bakke, Helvi Holm Samdal, Jens J. Holst, +12

Scandinavian Journal of Immunology

Meningococcal Outer Membrane Vesicle Vaccine Given Intranasally Can Induce Immunological Memory and Booster Responses without Evidence of Tolerance

Hilde Bakke, Kristian Lie, Inger Lise Haugen, +7

Infection and Immunity

VaccinationMucosal VaccinationVeterinary VaccineVaccine DevelopmentVaccine Target +11

Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant.

Bjørn Haneberg, Rolf Dalseg, Fredrik Oftung, +9

PubMed

VaccinationVaccinologyInfluenza VirusMucosal VaccinationVaccine Development +13

Intranasal Administration of a Therapeutic HIV Vaccine (Vacc-4x) Induces Dose-Dependent Systemic and Mucosal Immune Responses in a Randomized Controlled Trial

Kristin Brekke, Andreas Lind, Carol Holm‐Hansen, +4

PLoS ONE